Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.

CorMedix Inc

CRMD
5,16
-0,03 (-0,58%)
08 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
06/6/202414:30GLOBECorMedix Inc. Announces CMS Grants Pass-Through Status to..
23/5/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
13/5/202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202423:06EDGAR2Form S-3 - Registration statement under Securities Act of..
09/5/202414:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202413:40EDGAR2Form 8-K - Current report
19/4/202414:30GLOBECorMedix Inc. Announces CMS Grants TDAPA to DefenCath
15/4/202414:30GLOBECorMedix Inc. Announces U.S. Inpatient Commercial..
12/3/202412:30GLOBECorMedix Inc. Reports Fourth Quarter and Full Year 2023..
30/1/202423:26EDGAR2Form 8-K - Current report
18/1/202402:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202402:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202402:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202402:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202314:39EDGAR2Form 8-K - Current report
14/12/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202322:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202322:11EDGAR2Form 8-K - Current report
14/11/202322:05GLOBECorMedix Inc. Reports Third Quarter and Nine Month 2023..
30/10/202321:35EDGAR2Form 8-K - Current report
11/10/202314:30GLOBECorMedix Inc. Announces Abstract Presentation at Upcoming..
13/9/202323:25EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
13/9/202323:20EDGAR2Form DEF 14A - Other definitive proxy statements
08/9/202322:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/9/202314:30GLOBECorMedix Inc. Announces Publication of Phase 3 LOCK IT-100..
30/8/202314:00GLOBECorMedix Inc. Announces Issuance of U.S. Patent Covering..
17/8/202314:30EDGAR2Form 8-K - Current report
08/8/202314:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202313:45EDGAR2Form 8-K - Current report
08/8/202313:30GLOBECorMedix Inc. Reports Second Quarter and Six Month 2023..
30/6/202322:40EDGAR2Form 8-K - Current report
30/6/202322:38EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/6/202304:57GLOBECorMedix Inc. Announces Pricing of $40 Million Public..
28/6/202323:13EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
28/6/202322:07GLOBECorMedix Inc. Announces Proposed Public Offering of Common..
21/6/202314:30GLOBECorMedix Inc. Announces FDA Acceptance of Resubmission of..
15/6/202314:30GLOBECormedix Inc. Announces Strategic Initiative With Boston..
Apertura: 5,15 Min: 5,07 Max: 5,195
Chiusura: 5,19

La tua Cronologia

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network